Clinical trials
Phase 3 Nephrolithiasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insel Gruppe AG, University Hospital Bern | 2 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| Hans Bahlmann | 1 |
| Mansoura University | 1 |
| Montefiore Medical Center | 1 |
| National Center for Research Resources (NCRR) | 1 |
| Sengkang General Hospital | 1 |
| Shiraz University of Medical Sciences | 1 |
| Unity Health Toronto | 1 |
| Universitair Ziekenhuis Brussel | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nephrolithiasis | 12 |
| Urolithiasis | 4 |
| Kidney Calculi | 3 |
| Hypercalciuria | 2 |
| Acute Pain | 1 |
| Calcium Metabolism Disorders | 1 |
| Hyperoxaluria | 1 |
| Hypocalcemia | 1 |
| Hypoparathyroidism | 1 |
| Kidney Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.